{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T00:54:15Z","timestamp":1785200055107,"version":"3.55.0"},"reference-count":59,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2019,3,15]],"date-time":"2019-03-15T00:00:00Z","timestamp":1552608000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Microbiol."],"DOI":"10.3389\/fmicb.2019.00475","type":"journal-article","created":{"date-parts":[[2019,3,15]],"date-time":"2019-03-15T04:53:00Z","timestamp":1552625580000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":13,"title":["Clinical Significance of Polymorphisms in Immune Response Genes in Hepatitis C-Related Hepatocellular Carcinoma"],"prefix":"10.3389","volume":"10","author":[{"given":"Valli","family":"De Re","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Lina","family":"Tornesello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariangela","family":"De Zorzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Caggiari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Pezzuto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrizia","family":"Leone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vito","family":"Racanelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gianfranco","family":"Lauletta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Gragnani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela","family":"Buonadonna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emanuela","family":"Vaccher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna Linda","family":"Zignego","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agostino","family":"Steffan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Franco M.","family":"Buonaguro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2019,3,15]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1186\/s12879-017-2921-8","article-title":"Estimating the scale of chronic hepatitis B virus infection among migrants in EU\/EEA countries.","volume":"18","author":"Ahmad","year":"2018","journal-title":"BMC Infect. Dis."},{"key":"B2","year":"2018"},{"key":"B3","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1038\/nature04444","article-title":"Restoring function in exhausted CD8 T cells during chronic viral infection.","volume":"439","author":"Barber","year":"2006","journal-title":"Nature"},{"key":"B4","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1007\/s00262-004-0593-x","article-title":"Interaction of PD-L1 on tumor cells with PD-1 on tumor-specific T cells as a mechanism of immune evasion: implications for tumor immunotherapy.","volume":"54","author":"Blank","year":"2005","journal-title":"Cancer Immunol. Immunother."},{"key":"B5","doi-asserted-by":"publisher","first-page":"4215","DOI":"10.1128\/JVI.02844-06","article-title":"Characterization of hepatitis B virus (HBV)-specific T-cell dysfunction in chronic HBV infection.","volume":"81","author":"Boni","year":"2007","journal-title":"J. Virol."},{"key":"B6","year":"2018","journal-title":"Draft ACIP Hepatitis Recommandations."},{"key":"B7","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1189\/jlb.0207128","article-title":"Toll-like receptors 1 and 6 are involved in TLR2-mediated macrophage activation by hepatitis C virus core and NS3 proteins.","volume":"82","author":"Chang","year":"2007","journal-title":"J. Leukoc. Biol."},{"key":"B8","doi-asserted-by":"publisher","first-page":"E5900","DOI":"10.1073\/pnas.1706559114","article-title":"Delineation of an immunosuppressive gradient in hepatocellular carcinoma using high-dimensional proteomic and transcriptomic analyses.","volume":"114","author":"Chew","year":"2017","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"B9","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1038\/nature05115","article-title":"PD-1 expression on HIV-specific T cells is associated with T-cell exhaustion and disease progression.","volume":"443","author":"Day","year":"2006","journal-title":"Nature"},{"key":"B10","doi-asserted-by":"publisher","first-page":"1205","DOI":"10.1053\/j.gastro.2007.02.009","article-title":"B-cell lymphomas associated with HCV infection.","volume":"132","author":"De Re","year":"2007","journal-title":"Gastroenterology"},{"key":"B11","doi-asserted-by":"publisher","first-page":"37487","DOI":"10.18632\/oncotarget.9303","article-title":"HCV-related liver and lymphoproliferative diseases: association with polymorphisms of IL28B and TLR2.","volume":"7","author":"De Re","year":"2016","journal-title":"Oncotarget"},{"key":"B12","doi-asserted-by":"publisher","first-page":"1513","DOI":"10.1053\/j.gastro.2004.08.067","article-title":"core and nonstructural 3 proteins trigger toll-like receptor 2-mediated pathways and inflammatory activation.","volume":"127","author":"Dolganiuc","year":"2004","journal-title":"Gastroenterology"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1128\/mBio.00819-17","article-title":"Type III interferon-mediated signaling is critical for controlling live attenuated yellow fever virus infection in vivo.","volume":"8","author":"Douam","year":"2017","journal-title":"mBio"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1038\/emi.2014.51","article-title":"The impact of the interferon-lambda family on the innate and adaptive immune response to viral infections.","volume":"3","author":"Egli","year":"2014","journal-title":"Emerg. Microbes Infect."},{"key":"B15","doi-asserted-by":"publisher","first-page":"2492","DOI":"10.1016\/S0140-6736(17)31046-2","article-title":"Nivolumab in patients with advanced hepatocellular carcinoma (CheckMate 040): an open-label, non-comparative, phase 1\/2 dose escalation and expansion trial.","volume":"389","author":"El-Khoueiry","year":"2017","journal-title":"Lancet"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1186\/s12879-017-2908-5","article-title":"Estimating the scale of chronic hepatitis C virus infection in the EU\/EEA: a focus on migrants from anti-HCV endemic countries.","volume":"18","author":"Falla","year":"2018","journal-title":"BMC Infect. Dis."},{"key":"B17","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1007\/s10875-011-9547-1","article-title":"Role of interleukin 28B rs12979860 C\/T polymorphism on the histological outcome of chronic hepatitis C: relationship with gender and viral genotype.","volume":"31","author":"Falleti","year":"2011","journal-title":"J. Clin. Immunol."},{"key":"B18","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1053\/j.gastro.2009.09.052","article-title":"Antiviral intrahepatic T-cell responses can be restored by blocking programmed death-1 pathway in chronic hepatitis B.","volume":"138","author":"Fisicaro","year":"2010","journal-title":"Gastroenterology"},{"key":"B19","doi-asserted-by":"publisher","first-page":"15001","DOI":"10.1073\/pnas.1312772110","article-title":"Immunotherapy of chronic hepatitis C virus infection with antibodies against programmed cell death-1 (PD-1).","volume":"110","author":"Fuller","year":"2013","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"B20","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1038\/nature08309","article-title":"Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance.","volume":"461","author":"Ge","year":"2009","journal-title":"Nature"},{"key":"B21","doi-asserted-by":"publisher","first-page":"9249","DOI":"10.1128\/JVI.00409-07","article-title":"Upregulation of PD-1 expression on circulating and intrahepatic hepatitis C virus-specific CD8+ T cells associated with reversible immune dysfunction.","volume":"81","author":"Golden-Mason","year":"2007","journal-title":"J. Virol."},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2017.01707","article-title":"Interferon lambda genetics and biology in regulation of viral control.","volume":"8","author":"Hemann","year":"2017","journal-title":"Front. Immunol."},{"key":"B23","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1038\/s41395-018-0008-9","article-title":"How we approach it: treatment options for hepatocellular carcinoma.","volume":"113","author":"Hernaez","year":"2018","journal-title":"Am. J. Gastroenterol."},{"key":"B24","doi-asserted-by":"publisher","first-page":"1379","DOI":"10.1111\/j.1478-3231.2010.02323.x","article-title":"Increased PD-1 and decreased CD28 expression in chronic hepatitis B patients with advanced hepatocellular carcinoma.","volume":"30","author":"Hsu","year":"2010","journal-title":"Liver Int."},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-16011-2","article-title":"Fine-mapping of genetic loci driving spontaneous clearance of hepatitis C virus infection.","volume":"20","author":"Huang","year":"2017","journal-title":"Sci. Rep."},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1186\/s13046-016-0412-1","article-title":"Deletion of interleukin-6 in monocytes\/macrophages suppresses the initiation of hepatocellular carcinoma in mice.","volume":"35","author":"Kong","year":"2016","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"B27","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1159\/000449342","article-title":"Immune checkpoint blockade in hepatocellular carcinoma: 2017 update.","volume":"6","author":"Kudo","year":"2016","journal-title":"Liver Cancer"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000005749","article-title":"Immune checkpoint proteins PD-1 and TIM-3 are both highly expressed in liver tissues and correlate with their gene polymorphisms in patients with HBV-related hepatocellular carcinoma.","volume":"95","author":"Li","year":"2016","journal-title":"Medicine"},{"key":"B29","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1016\/j.meegid.2012.12.008","article-title":"Genetic variations of PD1 and TIM3 are differentially and interactively associated with the development of cirrhosis and HCC in patients with chronic HBV infection.","volume":"14","author":"Li","year":"2013","journal-title":"Infect. Genet. Evol."},{"key":"B30","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1007\/s00296-009-1264-1","article-title":"Programmed cell death 1 gene polymorphisms is associated with ankylosing spondylitis in chinese han population.","volume":"31","author":"Liu","year":"2011","journal-title":"Rheumatol. Int."},{"key":"B31","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1056\/NEJMoa0708857","article-title":"Sorafenib in advanced hepatocellular carcinoma.","volume":"359","author":"Llovet","year":"2008","journal-title":"N. Engl. J. Med."},{"key":"B32","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1007\/BF02936370","article-title":"Elevation of interleukin 6 levels in patients with chronic hepatitis due to hepatitis C virus.","volume":"32","author":"Malaguarnera","year":"1997","journal-title":"J. Gastroenterol."},{"key":"B33","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1016\/j.diabres.2008.12.003","article-title":"Interactions between programmed death 1 (PD-1) and cytotoxic T lymphocyte antigen 4 (CTLA-4) gene polymorphisms in type 1 diabetes.","volume":"83","author":"Momin","year":"2009","journal-title":"Diabetes Res. Clin. Pract."},{"key":"B34","doi-asserted-by":"publisher","first-page":"6469","DOI":"10.3748\/wjg.v22.i28.6469","article-title":"Specific CD8(+) T cell response immunotherapy for hepatocellular carcinoma and viral hepatitis.","volume":"22","author":"Moreno-Cubero","year":"2016","journal-title":"World J. Gastroenterol."},{"key":"B35","doi-asserted-by":"publisher","first-page":"5801","DOI":"10.4049\/jimmunol.1401936","article-title":"PD-1 upregulated on regulatory T cells during chronic virus infection enhances the suppression of CD8+ T cell immune response via the interaction with PD-L1 expressed on CD8+ T cells.","volume":"194","author":"Park","year":"2015","journal-title":"J. Immunol."},{"key":"B36","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1016\/j.meegid.2015.08.018","article-title":"Association of genetic polymorphisms in CD8+ T cell inhibitory genes and susceptibility to and progression of chronic HBV infection.","volume":"36","author":"Peng","year":"2015","journal-title":"Infect. Genet. Evol."},{"key":"B37","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1002\/hep.21541","article-title":"Dysfunction and functional restoration of HCV-specific CD8 responses in chronic hepatitis C virus infection.","volume":"45","author":"Penna","year":"2007","journal-title":"Hepatology"},{"key":"B38","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1038\/nrgastro.2015.173","article-title":"Immunological landscape and immunotherapy of hepatocellular carcinoma.","volume":"12","author":"Prieto","year":"2015","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"B39","doi-asserted-by":"publisher","first-page":"2545","DOI":"10.1128\/JVI.02021-06","article-title":"Liver-infiltrating lymphocytes in chronic human hepatitis C virus infection display an exhausted phenotype with high levels of PD-1 and low levels of CD127 expression.","volume":"81","author":"Radziewicz","year":"2007","journal-title":"J. Virol."},{"key":"B40","doi-asserted-by":"publisher","first-page":"1237","DOI":"10.1111\/1469-0691.12797","article-title":"Hepatitis C virus and interferon type III (interferon-lambda3\/interleukin-28B and interferon-lambda4): genetic basis of susceptibility to infection and response to antiviral treatment.","volume":"20","author":"Riva","year":"2014","journal-title":"Clin. Microbiol. Infect."},{"key":"B41","doi-asserted-by":"publisher","first-page":"1312","DOI":"10.1002\/cncr.29936","article-title":"Annual report to the nation on the status of cancer, 1975-2012, featuring the increasing incidence of liver cancer.","volume":"122","author":"Ryerson","year":"2016","journal-title":"Cancer"},{"key":"B42","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1007\/s00251-017-1015-5","article-title":"PD-1 and cancer: molecular mechanisms and polymorphisms.","volume":"70","author":"Salmaninejad","year":"2018","journal-title":"Immunogenetics"},{"key":"B43","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.1200\/JCO.2010.31.8907","article-title":"Targeting the interleukin-6\/Jak\/stat pathway in human malignancies.","volume":"20","author":"Sansone","year":"2012","journal-title":"J. Clin. Oncol."},{"key":"B44","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1093\/rheumatology\/kel425","article-title":"Hepatitis C virus infection, cryoglobulinaemia, and beyond.","volume":"46","author":"Sansonno","year":"2007","journal-title":"Rheumatology"},{"key":"B45","doi-asserted-by":"publisher","first-page":"1035","DOI":"10.3892\/mco.2014.358","article-title":"PD-1 gene promoter polymorphisms correlate with a poor prognosis in non-small cell lung cancer.","volume":"2","author":"Sasaki","year":"2014","journal-title":"Mol. Clin. Oncol."},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2017.00119","article-title":"Interferon lambda: modulating immunity in infectious diseases.","volume":"8","author":"Syedbasha","year":"2017","journal-title":"Front. Immunol."},{"key":"B47","first-page":"763","article-title":"Association of programmed cell death-1 (PDCD-1) gene polymorphisms with rheumatoid arthritis in Iranian patients.","volume":"29","author":"Tahoori","year":"2011","journal-title":"Clin. Exp. Rheumatol."},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0067301","article-title":"IL28B gene polymorphisms and US liver fatty changes in patients who spontaneously cleared hepatitis C virus infection.","volume":"8","author":"Taliani","year":"2013","journal-title":"PLoS One"},{"key":"B49","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.1038\/ng.449","article-title":"Genome-wide association of IL28B with response to pegylated interferon-alpha and ribavirin therapy for chronic hepatitis C.","volume":"41","author":"Tanaka","year":"2009","journal-title":"Nat. Genet."},{"key":"B50","doi-asserted-by":"publisher","first-page":"39198","DOI":"10.18632\/oncotarget.17338","article-title":"Programmed death-1 polymorphisms is associated with risk of esophagogastric junction adenocarcinoma in the chinese han population: a case-control study involving 2,740 subjects.","volume":"8","author":"Tang","year":"2017","journal-title":"Oncotarget"},{"key":"B51","doi-asserted-by":"publisher","first-page":"219","DOI":"10.2174\/1573397113666170104123113","article-title":"Case-control association study of autoimmunity associated variants in PDCD1 and juvenile idiopathic arthritis.","volume":"13","author":"Tejeda","year":"2017","journal-title":"Curr. Rheumatol. Rev."},{"key":"B52","doi-asserted-by":"publisher","first-page":"978","DOI":"10.1053\/j.gastro.2011.12.055","article-title":"HCV infection induces a unique hepatic innate immune response associated with robust production of type III interferons.","volume":"142","author":"Thomas","year":"2012","journal-title":"Gastroenterology"},{"key":"B53","doi-asserted-by":"publisher","first-page":"802","DOI":"10.1038\/ni.3212","article-title":"Guarding the frontiers: the biology of type III interferons.","volume":"16","author":"Wack","year":"2015","journal-title":"Nat. Immunol."},{"key":"B54","doi-asserted-by":"publisher","first-page":"3322","DOI":"10.3748\/wjg.v17.i28.3322","article-title":"Immunostaining of PD-1\/PD-Ls in liver tissues of patients with hepatitis and hepatocellular carcinoma.","volume":"17","author":"Wang","year":"2011","journal-title":"World J. Gastroenterol."},{"key":"B55","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.meegid.2015.02.022","article-title":"Genetic variations of IL-28B and PD-1 are in association with the susceptibility and outcomes of HCV infection in southeast china.","volume":"32","author":"Xiao","year":"2015","journal-title":"Infect. Genet. Evol."},{"key":"B56","doi-asserted-by":"publisher","first-page":"23","DOI":"10.5005\/jp-journals-10018-1253","article-title":"Diagnostic and prognostic role of serum interleukin-6 in malignant transformation of liver cirrhosis.","volume":"8","author":"Yakut","year":"2018","journal-title":"Eur. J. Hepatogastroenterol."},{"key":"B57","doi-asserted-by":"publisher","first-page":"18933","DOI":"10.18632\/oncotarget.3662","article-title":"microRNA-4717 differentially interacts with its polymorphic target in the PD1 3\u2019 untranslated region: a mechanism for regulating PD-1 expression and function in HBV-associated liver diseases.","volume":"6","author":"Zhang","year":"2015","journal-title":"Oncotarget"},{"key":"B58","doi-asserted-by":"publisher","first-page":"1209","DOI":"10.1016\/j.humimm.2010.08.014","article-title":"Association of polymorphisms of programmed cell death-1 gene with chronic hepatitis B virus infection.","volume":"71","author":"Zhang","year":"2010","journal-title":"Hum. Immunol."},{"key":"B59","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1159\/000495172","article-title":"Type III interferons in viral infection and antiviral immunity.","volume":"51","author":"Zhou","year":"2018","journal-title":"Cell Physiol. Biochem."}],"container-title":["Frontiers in Microbiology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fmicb.2019.00475\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,3,15]],"date-time":"2019-03-15T04:53:02Z","timestamp":1552625582000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fmicb.2019.00475\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3,15]]},"references-count":59,"alternative-id":["10.3389\/fmicb.2019.00475"],"URL":"https:\/\/doi.org\/10.3389\/fmicb.2019.00475","relation":{},"ISSN":["1664-302X"],"issn-type":[{"value":"1664-302X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,3,15]]},"article-number":"475"}}